-
Monthly COVID-19 Hospitalization Rates Peaked in December 2020
drugs
August 11, 2021
For adults hospitalized with COVID-19, monthly rates of hospitalization, intensive care unit (ICU) admission, and death peaked in December 2020, according to a study published online Aug. 10 in the Annals of Internal Medicine.
-
Lam Research funds the expansion of critical care infrastructure at Hassan Institute of Medical Sciences (HIMS), Karnataka
prnasia
July 20, 2021
Lam Research today announced the funding of additional critical care facilities at the Hassan Institute of Medical Sciences (HIMS), Karnataka. As part of the initiative, 18 Intensive Care Unit (ICU) beds have been added at the institution in ...
-
Aspirin may decrease ICU admission and death in COVID-19 patients
europeanpharmaceuticalreview
March 18, 2021
In a new study, low dose aspirin reduced risk of mechanical ventilation, ICU admission and in-hospital mortality by over 40 percent each.
-
Increased heparin dose reduces need for life support in hospitalised COVID-19 patients
europeanpharmaceuticalreview
January 26, 2021
Interim data from 1,000 hospitalised patients with moderate COVID-19 symptoms shows that full doses of heparin can improve patient outcomes and could reduce ICU burden.
-
Study finds tocilizumab improves survival in critically ill patients with COVID-19
worldpharmanews
October 23, 2020
Researchers from 68 sites across the country, led by David E. Leaf, MD, MMSc and Shruti Gupta, MD, MPH from the Division of Renal Medicine at Brigham and Women's Hospital, have investigated the effects of the anti-inflammatory drug tocilizumab on ...
-
Hackensack Meridian Health Observational Study Identifies Drug that Improves Survival in Sickest COVID-19 Patients
prnewswire
August 20, 2020
Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in ...
-
Oral bacteriotherapy improved outcomes in COVID-19 patients
europeanpharmaceuticalreview
July 15, 2020
Clinical trial testing a live biotherapeutic in hospitalised COVID-19 patients suggests the bacteriotherapy could be promising.
-
Remdesivir can save more lives where ICUs are overwhelmed
worldpharmanews
July 08, 2020
Amid news that the United States has bought up virtually the entire global supply of remdesivir, a new Boston University School of Public Health (BUSPH) study outlines how the drug could save lives in countries with less hospital capacity ...
-
Researchers identify six potential drug targets for COVID-19
expresspharma
June 28, 2020
The tumour necrosis factor, granzyme B, heat shock protein 70, interleukin-18, interferon-gamma-inducible protein 10, and elastase were found elevated in COVID-19 ICU patients.
-
Health Ministry asks AIOCD to ensure availability of critical drugs for management of COVID-19
expresspharma
May 06, 2020
The ministry has forwarded a list of 55 drugs for ICU management of novel coronavirus patients and a list of another 96 drugs for general availability and treatment of various co-morbid conditions.